Manuscript Ref. No.: PONE-D-20-19173
Title: Toll like Receptor signalling by Prevotella histicola activates alternative
NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P.aeruginosa
We thank the reviewers and the editor for their careful review of the manuscript and
their overall very positive assessment. We have now addressed all issues raised and
modified the manuscript in a revised version.
Please find below our point-by-point response to the issues pointed out.
Journal Requirements:
Please ensure that your manuscript meets PLOS ONE's style requirements, including
those for file naming.
This has been modified according to the PLOS ONE's style requirements.
Please amend either the title on the online submission form (via Edit Submission)
or the title in the manuscript so that they are identical.
The title in the online submission has been changed to “Toll like Receptor signalling
by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis
bronchial epithelial cells compared to P. aeruginosa”.
Please include captions for your Supporting Information files at the end of your manuscript,
and update any in-text citations to match accordingly.
This has been modified according to the PLOS ONE's requirements.
Response to Reviewers' comments:
Reviewer #1:
Q1) In terms of the issue of higher HIF alpha expression level in healthy vs CF lungs
(Review paper by Montgomery et al 2017), would be nice to indicate the microbiome
diversity/dominant species composition in relation to this report.
A1) We have now added more detailed information about dominant anaerobe species into
the manuscript (line 347-363). This now reads:
“The relative abundance of anaerobic bacteria compared to aerobic bacteria in CF sputum
is associated with a milder disease when compared to Pseudomonas-dominated patients.
In a large multisite study involving clinical stable CF patients from the UK, Ireland
and the US, Muhlebach et al. showed the culture of 18 anaerobic genera from 59% of
sputum samples (95% aerobic). Significantly prevalent anaerobes were Prevotella species,
followed by Veillonella, Porphyromonas and others. Importantly, the prevalence of
anaerobes was positively associated with pancreatic sufficiency, better nutrition
and better lung function (Muhlebach, Hatch et al. 2018). Consistent with this, reduced
bacterial diversity and increased levels of inflammation have also been reported in
patients with CF (Zemanick, Harris et al. 2013, O'Neill, Bradley et al. 2015). A lower
abundance of aerobic and anaerobic bacteria reflecting microbiota disruption was shown
to be associated with disease progression (lower lung clearance index (LCI) and higher
CRP in the CF lung (O'Neill, Bradley et al. 2015). Zemanick et al. investigated the
presence of anaerobes in early CF exacerbations showing the highest relative abundance
for Prevotella, Veillonella and Porphyromonas. Higher levels of sputum anaerobes
were associated with less inflammation and higher lung function compared to the presence
of Pseudomonas at exacerbation (Zemanick, Harris et al. 2013). However, while the
weak inflammatory properties of commensal Prevotella spp. ….. “
Reviewer #2:
Q2) My most pressing concern is the paucity of methodological detail. Much more extensive
detail should be added to methods sections. As an example, the "infection assays"
section is a single sentence and is missing a great deal of pertinent information.
As the manuscript currently stands, I doubt others would be able to recapitulate the
results presented, based on the level of detail in the methods.
A2) We have now added more methodological detail into the manuscript. Further details
can now also be found in the supplement (S1 Text, Materials & Methods).
The revised version now reads:
“Materials and Methods
Bacterial culture
The bacterial isolates used in this study were all obtained from patients attending
the adult CF clinic at Belfast City Hospital. The isolates were derived from two different
patients enrolled in a multicentre study (Office for Research Ethics Committees Northern
Ireland (OREC) 10/NIR01/41; Integrated Research Approval System (IRAS) Project no.
41579) as previously described (17).
The clinical isolate of P. histicola B011L was cultured under anaerobic conditions
for 72 hours on Columbia Blood Agar (CBA, Fannin LIP) using a Don Whitley anaerobic
cabinet (Don Whitley A35 workstation) as described (Tunney, Field et al. 2008). This
lawn of colonies was used to inoculate 10mL of anaerobic basal broth (Oxoid)TO OD.0.1
and this was allowed to grow to mid log phase (approximately 18 hours). This culture
was used for infection experiments. P. histicola was identified by 16S rRNA sequencing,
PGFE and RAPD analysis as described (Gilpin, Nixon et al. 2017, Bertelsen, Elborn
et al. 2019).
P. aeruginosa (clinical isolate B021, identified using 16S rRNA screening (Gilpin,
Nixon et al. 2017)) was grown under aerobic conditions on Columbia blood agar (CBA)
(37°C, 5% CO2, 95% mixed gas) over night. This culture was then utilised to inoculate
a 10 mL culture of Lysogeny Broth (LB broth), The start OD was 0.05. This broth culture
was incubated for up to two hours at 200 rpm, 37°C until mid-log phase under aerobic
conditions (approximately 3-4 hours) prior to being used for further cell infections
under anaerobic conditions.
The minimum amount of bacteria required to provoke a significant response from CFBE41o-
cells (0-4h, anaerobic conditions) was determined by screening of 3 different P. aeruginosa
isolates as described (Bertelsen, Elborn et al. 2019). Growth curves of P. histicola
and P. aeruginosa under anaerobic conditions revealed no differences in the growth
rates between the two species (S1 Fig).
Cell culture
The F508del homozygote cystic fibrosis cell line (CFBE41o-) was maintained in antibiotic
free minimum essential media (MEM, Gibco), supplemented with 10% heat inactivated
foetal bovine serum (FBS, Gibco) and 5% L-Glutamine (Gibco) under standard cell culture
conditions (37°C, 5% CO2, 95% mixed gas). All tissue culture flasks and plates were
pre-coated with a 1 % PurCol type 1 collagen solution (Nutacon) and passaged as described
previously (Buchanan, Ernst et al. 2009). HEK-293-TLR2, HEK-293-TLR4, HE-293-TLR5
and HEK-293-TLR null cells were maintained as per manufacturer’s instructions (InvivoGen).
Infection assays
CFBE41o- cells were infected with P. histicola or P. aeruginosa at an MOI (Multiplicity
of Infection) of 100 for 4 hours. Both bacteria were grown to mid log phase as described
previously (Bertelsen, Elborn et al. 2019). An MOI of 100 was defined by plating all
inocula on CBA agar and enumerating viable counts the following morning. Liquid cultures
were used to inoculate cells for infection experiments and cells were incubated for
up to 4 hours under anaerobic conditions as described above. Cells were incubated
under anaerobic conditions for the duration of the experiments as described in supplementary
data (S1 Text).
Cell viability assays
To confirm that experimental conditions would not negatively affect cell viability,
lactate dehydrogenase release (LDH, Abcam), mitochondrial respiration (MTT) and trypan
blue exclusion were assessed after exposure to hypoxia and bacteria.
Briefly, bell death was assessed by measuring LDH release from infected cells and
non-infected control cells. 10μL of supernatant was used for each assay as per manufacturer’s
instructions (Abcam, ab69693). Analyses of mitochondrial activation (measured by MTT
(3- [4, 5-dimethyl thiazol-2yl] – 2, 5 diphenyl tetrazolium bromide) conversion to
purple formazan (absorbance λ=570nm)) served as a surrogate for cell viability. Trypan
Blue (Sigma) was used in the dye exclusion assay. After incubation and loading onto
a Neubauer haemocytometer, cells which appeared blue under the microscope were determined
as ‘dead’ and cells appearing white were counted as ‘live cells’. Further details
of these assays can be found in the supplement. (S2 Fig (A-C)).
TLR Reporter assays
HEK-293-TLR2, HEK-293-TLR4 and HEK-293-TLR5 cells were purchased from InvivoGen and
cultured and transfected as per manufacturer’s instructions. Briefly, HEK-293 cells
were maintained in high Glucose DMEM with 10% FBS, L-Glutamine and Pen/Strep. 100μg
Blasticidin was added to cells after the second passage and cells were maintained
in the media thereafter. Cells were transiently transfected with an NF-�B containing reporter construct plasmid (LyoVec and pNifty-Luc™, InvivoGen) and cells
were incubated for 24 hours under standard tissue culture conditions to recover from
the transfection. Bacterial infection was carried out as described (Bertelsen, Elborn
et al. 2019) and cells were incubated under anaerobic conditions for the duration
of the experiments.
Cytoplasmic and nuclear fraction extraction for DNA binding ELISA
…
RT-PCR for TLR and Cytokine gene expression
…
siRNA knockdown assays
…
Statistical analysis
…”
Q3) Growth rate comparison between P. aeruginosa and P. histicola is not standard.
Cells should be inoculated at low enough density to monitor lag phase and tracked
for long enough to capture log and stationary phases. Minimally, more than 1 doubling
should be measured for a true growth rate calculation. It appears that doubling time
here is ~4 hours, but at what part of the growth curve are we looking at? Furthermore,
the methods here are lacking and the cited reference (Tunney et al 2007 AJRCCM) does
not provide any detail germaine to the method at hand, perhaps it is the wrong reference?
Regardless, the authors should provide full methodological detail here (and for other
sections). For instance, how did the authors so precisely obtain the exact same number
of cells reported for each species for the first time point? This result is important
to bolster in order to support claims made by the authors (for instance on lines 360-361).
A3) Both strains were grown under different conditions as they require distinct conditions.
P.aeruginosa will grow quite well from a start OD 590 of 0.01, through lag, log and
lag phases while Prevotella spp. will not grow well with an initial low inoculum ,
an takes approx. 18 hours to reach exponential growth. Therefore, conditions were
optimized to reflect this. The same number of bacteria were added to each cell infection
as defined by OD and plating of CFU/mL, where the OD differed between the two species.
The paper by Tunney et al. (2007) is quoted as it refers to the culture of Prevotella
spp.
The materials and methods section has now been extended in the manuscript and the
supplement.
Q4) The authors use the term "infection" when referring to the experiments described
in Fig 1. Do they mean that they are modeling infection of the airway by applying
bacteria to cell culture? Or are they specifically referring to infection of their
cells by bacteria becoming internalized? Commonly, for infection assays involving
bacteria, there is a question of how many bacteria are internalized versus remain
extracellular upon treatment. A useful method is to incubate bacteria with cultured
cells, allow for internalization, then treat with antibiotic (e.g. gentamicin) to
kill extracellular bacteria, and subsequent washing of cells. Assessment of bacterial
internalization can then be performed by cfu plating or qPCR. Since the authors do
not report doing this, presumably they do not know if bacteria are internalized or
not, and if there are differences in the abundance of internalized Ph versus Pa bacteria.
TLR5 signaling I believe does not require internalization, therefore perhaps what
they are observing is detection of extracellular bacteria. If this is true, and/or
if this is what the authors mean (as seems to be indicated by the graphic depiction
in Figure 5), I recommend changing the term "infection" to something like "exposure".
A4) Gentamycin protection assays were carried out to ascertain if bacteria were being
internalized. Bacteria were screened for susceptibility to Gentamycin and the lowest
concentration (20 µg in 2 hours) was employed for internalization.
Briefly, cells were infected with either P. histicola or P. aeruginosa for 1 or 2
hours, supernatants were removed, cells were washed 3 times with pre-warmed, sterile
PBS and media was replaced with media containing concentrations of either 20 μg or
50 μg Gentamycin.
Cells were incubated anaerobically for an additional 2 hours, and supernatants were
plated to ensure extra cellular bacteria were no longer viable. Infected epithelial
cells were then lysed with 1 % Saponin (5 minutes incubation, with further gentle
manual lysis) and cell lysates plated onto CBA and incubated overnight aerobically
for P. aeruginosa or anaerobically for P. histicola. The ability of the bacteria to
remain viable in the presence of either 0.5 % Triton – X 100 or saponin was assessed,
with saponin being deemed to be suitable for these assays.
Due to the inability to keep the cells for longer than 4 hours under anaerobic conditions
it was not possible to add an additional, lower bacteria-static concentration of gentamycin
to the infected cells ie. 10 μg and incubate further, however these assays showed
that all extracellular bacteria were non-viable after 1 or 2 hours in the presence
of either concentration of Gentamycin. In our hands there was no internalization of
these bacterial strains by the cells under our experimental conditions. While there
is a possibility that, at the higher concentration of Gentamycin, the Gentamycin may
have been internalized and killed any intracellular bacteria, the lack of intracellular
bacteria detected with either concentrations indicates that these bacteria were not
up-taken by the epithelial cells and remained extracellular for the duration of our
experiments.
Infection is not only defined by bacterial uptake. Exposure of our bacterial strains
to epithelial cells caused an inflammatory response we refer to as infection. Both
Pseudomonas and Prevotella strains secrete outer membrane vehicles (OMVs), which are
up taken by cells and provoke an inflammatory response (Metruccio, Evans et al. 2016,
Yang, Chen et al. 2019). This shows that infection and subsequent inflammation cannot
solely be attributed to bacterial uptake.
Figure 5 is a schematic representation of the investigated signalling pathways induced
by infections of CFBE41o- cells. The interaction of bacteria with the tested TLRs
(TLR5, TLR2) should occur in the first instance at the cell membrane. However, in
this study we did not investigate at which time point TLR signalling would cease.
Q5) P.histicola and P.aeruginosa – there should be a space following “P.” throughout
the text
A5) We thank the reviewer for pointing this out. This has been modified throughout
the text.
Q6) Lines 90-91 should be cited. In general, more statements throughout the text that
are presented as facts, should be supported by references to published literature.
Another example is the first line of the Discussion lines 339-340, and lines 367-369.
A6) We thank the reviewer for pointing this out. This has been modified and reads
as follows:
Line 90-91: “In CF airway diseases, the canonical NF-�B signalling pathway, consisting of the p65 and p50 subunits, and its role in inflammation
in CF has been extensively investigated (Blackwell, Stecenko et al. 2001, Kelly, Williams
et al. 2013, Bertelsen, Elborn et al. 2019), ….”
Line 339-340 (now line 371-372): “In CF airways, infections with bacterial species
such as P.aeruginosa, Burkholderia cepecia complex, Haemophilus influenza and S.aureus
are well investigated (Tang, Turvey et al. 2014, Zemanick and Hoffman 2016, Bevivino,
Bacci et al. 2019).”
Line 367-369 (now line 411-413): “TLRs (especiallyTLR2, 4 and 5) in the CF lung are
one of the most common innate immune defences activated in response to infection leading
to the activation of the classical NF-kB-activation and subsequent pro-inflammatory
cytokine release (Greene, Carroll et al. 2005, John, Yildirim et al. 2010, Kelly,
Canning et al. 2013, Kosamo, Hisert et al. 2020).”
Q7) Line 454, typo “aerugiosa”,
Line 362, typo “.f” at the end of the line.
A7) We thank the reviewer for pointing this out. This has been corrected.
Reviewer #3:
Q8). The results should be validated in another CF cell line.
A8) The CFBE41o- cell line is homozygous for F508del and has been extremely well characterized
in terms of both their immune responses and their ability to polarize and form tight
junctions under appropriate cell culture conditions. It further displays defective
cAMP dependent chloride transport while maintaining intact calcium dependent chloride
transport. For these reasons, this cell line is deemed to be a very robust and appropriate
model for CF studies, and we opted to work with this cell line over other, less well-characterized
cell lines for these reasons.
Q9) The authors report the mRNA levels of IL-8, IL-6 and CXCL1 (Figure 1). They should
also report the corresponding secreted protein levels.
A9) Aerobic experiments showed that CFBE and HBE cells, under submerged conditions
did not secrete significant levels of cytokines at 4 hours in response to various
concentrations of LPS, P. aeruginosa infection with a range of clinical isolates and
the lab strain PAO1 as well as bacterial whole cell lysates. Significant levels of
secreted cytokines were only observed at 6 hours post infection/ exposure to the various
treatments. As we could only maintain the cells for 4 hours under anaerobic conditions,
we opted to use qRT-PCR cytokine gene expression to assess cytokine responses to infection.
We were able to confirm that, under aerobic conditions, cells exposed to P. aeruginosa
infection displayed similar levels of cytokine gene expression at 2 and 4 hours as
compared to those incubated anaerobically and corresponding cytokine release was observed
from these cells at 6 hours. This indicates that should we have been able to maintain
the cells for longer under anaerobic conditions we would have seen IL-6, IL-8 and
CXCL-1 release from the epithelial cells in response to exposure to the bacteria,
as indicated by the gene expression.
References:
Bertelsen, A., et al. (2019). "Infection with Prevotella nigrescens induces TLR2 signalling
and low levels of p65 mediated inflammation in Cystic Fibrosis bronchial epithelial
cells." Journal of Cystic Fibrosis.
Bevivino, A., et al. (2019). "Deciphering the Ecology of Cystic Fibrosis Bacterial
Communities: Towards Systems-Level Integration." Trends Mol Med 25(12): 1110-1122.
Despite over a decade of cystic fibrosis (CF) microbiome research, much remains to
be learned about the overall composition, metabolic activities, and pathogenicity
of the microbes in CF airways, limiting our understanding of the respiratory microbiome's
relation to disease. Systems-level integration and modeling of host-microbiome interactions
may allow us to better define the relationships between microbiological characteristics,
disease status, and treatment response. In this way, modeling could pave the way for
microbiome-based development of predictive models, individualized treatment plans,
and novel therapeutic approaches, potentially serving as a paradigm for approaching
other chronic infections. In this review, we describe the challenges facing this effort
and propose research priorities for a systems biology approach to CF lung disease.
Blackwell, T. S., et al. (2001). "Dysregulated NF-kappaB activation in cystic fibrosis:
evidence for a primary inflammatory disorder." Am J Physiol Lung Cell Mol Physiol
281(1): L69-70.
Buchanan, P. J., et al. (2009). "Role of CFTR, Pseudomonas aeruginosa and Toll-like
receptors in cystic fibrosis lung inflammation." Biochem Soc Trans 37(Pt 4): 863-867.
CF (cystic fibrosis) is a severe autosomal recessive disease most common in Northwest
European populations. Underlying mutations in the CFTR (CF transmembrane conductance
regulator) gene cause deregulation of ion transport and subsequent dehydration of
the airway surface liquid, producing a viscous mucus layer on the airway surface of
CF patients. This layer is readily colonized by bacteria such as Pseudomonas aeruginosa.
Owing to the resulting environment and treatment strategies, the bacteria acquire
genetic modifications such as antibiotic resistance, biofilm formation, antimicrobial
peptide resistance and pro-inflammatory lipid A structures. Lipid A is a component
of the lipopolysaccharide cell wall present on bacteria and is recognized by TLR4
(Toll-like receptor 4). Its detection elicits a pro-inflammatory response that is
heightened over time due to the addition of fatty acids to the lipid A structure.
Eradication of bacteria from the lungs of CF patients becomes increasingly difficult
and eventually leads to mortality. In the present review, we describe the role of
lipid A as a virulent factor of Ps. aeruginosa; however, it appears that further work
is needed to investigate the role of CFTR in the innate immune response and in modifying
the pathogen-host interaction.
Gilpin, D. F., et al. (2017). "Evidence of persistence of Prevotella spp. in the cystic
fibrosis lung." J Med Microbiol: 825-832.
PURPOSE: Prevotella spp. represent a diverse genus of bacteria, frequently identified
by both culture and molecular methods in the lungs of patients with chronic respiratory
infection. However, their role in the pathogenesis of chronic lung infection is unclear;
therefore, a more complete understanding of their molecular epidemiology is required.
METHODOLOGY: Pulsed Field Gel Electrophoresis (PFGE) and Random Amplified Polymorphic
DNA (RAPD) assays were developed and used to determine the degree of similarity between
sequential isolates (n=42) from cystic fibrosis (CF) patients during periods of clinical
stability and exacerbation. RESULTS: A wide diversity of PFGE and RAPD banding patterns
were observed, demonstrating considerable within-genus heterogeneity. In 8/12 (66.7
%) cases, where the same species was identified at sequential time points, pre- and
post-antibiotic treatment of an exacerbation, PFGE/RAPD profiles were highly similar
or identical. Congruence was observed between PFGE and RAPD (adjusted Rand coefficient,
0.200; adjusted Wallace RAPD->PFGE 0.459, PFGE->RAPD 0.128). Furthermore, some isolates
could not be adequately assigned a species name on the basis of 16S rRNA analysis:
these isolates had identical PFGE/RAPD profiles to Prevotellahisticola. CONCLUSION:
The similarity in PFGE and RAPD banding patterns observed in sequential CF Prevotella
isolates may be indicative of the persistence of this genus in the CF lung. Further
work is required to determine the clinical significance of this finding, and to more
accurately distinguish differences in pathogenicity between species.
Greene, C. M., et al. (2005). "TLR-induced inflammation in cystic fibrosis and non-cystic
fibrosis airway epithelial cells." J Immunol 174(3): 1638-1646.
Cystic fibrosis (CF) is a genetic disease characterized by severe neutrophil-dominated
airway inflammation. An important cause of inflammation in CF is Pseudomonas aeruginosa
infection. We have evaluated the importance of a number of P. aeruginosa components,
namely lipopeptides, LPS, and unmethylated CpG DNA, as proinflammatory stimuli in
CF by characterizing the expression and functional activity of their cognate receptors,
TLR2/6 or TLR2/1, TLR4, and TLR9, respectively, in a human tracheal epithelial line,
CFTE29o(-), which is homozygous for the DeltaF508 CF transmembrane conductance regulator
mutation. We also characterized TLR expression and function in a non-CF airway epithelial
cell line 16HBE14o(-). Using RT-PCR, we demonstrated TLR mRNA expression. TLR cell
surface expression was assessed by fluorescence microscopy. Lipopeptides, LPS, and
unmethylated CpG DNA induced IL-8 and IL-6 protein production in a time- and dose-dependent
manner. The CF and non-CF cell lines were largely similar in their TLR expression
and relative TLR responses. ICAM-1 expression was also up-regulated in CFTE29o(-)
cells following stimulation with each agonist. CF bronchoalveolar lavage fluid, which
contains LPS, bacterial DNA, and neutrophil elastase (a neutrophil-derived protease
that can activate TLR4), up-regulated an NF-kappaB-linked reporter gene and increased
IL-8 protein production in CFTE29o(-) cells. This effect was abrogated by expression
of dominant-negative versions of MyD88 or Mal, key signal transducers for TLRs, thereby
implicating them as potential anti-inflammatory agents for CF.
John, G., et al. (2010). "TLR-4-mediated innate immunity is reduced in cystic fibrosis
airway cells." Am J Respir Cell Mol Biol 42(4): 424-431.
Airway epithelial cells contribute to the inflammatory response of the lung, and
their innate immune response is primarily mediated via Toll-like receptor (TLR) signaling.
Cystic fibrosis (CF) airways are chronically infected with Pseudomonas aeruginosa,
suggesting a modified immune response in CF. We investigated the TLR-4 expression
and the inflammatory profile (IL-8 and IL-6 secretion) in CF bronchial epithelial
cell line CFBE41o- and its CF transmembrane ion condcutance regulator (CFTR)-corrected
counterpart grown under air-liquid interface conditions after stimulation with lipopolysaccharide
(LPS) from gram-negative bacteria. In CFTR-corrected cells, IL-8 and IL-6 secretions
were constitutively activated but significantly increased after LPS stimulation compared
with CFBE41o-. Blocking TLR-4 by a specific antibody significantly inhibited IL-8
secretion only in CFTR-corrected cells. Transfection with specific siRNA directed
against TLR-4 mRNA significantly reduced the response to LPS in both cell lines. Fluorescence-activated
cell sorter analysis revealed significantly higher levels of TLR-4 surface expression
in CFTR-corrected cells. In histologic lung sections of patients with CF, the TLR-4
expression in the bronchial epithelium was significantly reduced compared with healthy
control subjects. In CF the loss of CFTR function appears to decrease innate immune
responses, possibly by altering the expression of TLR-4 on airway epithelial cells.
This may contribute to chronic bacterial infection of CF airways.
Kelly, C., et al. (2013). "Toll-like receptor 4 is not targeted to the lysosome in
cystic fibrosis airway epithelial cells." Am J Physiol Lung Cell Mol Physiol 304(5):
L371-382.
The innate immune response to bacterial infection is mediated through Toll-like receptors
(TLRs), which trigger tightly regulated signaling cascades through transcription factors
including NF-kappaB. LPS activation of TLR4 triggers internalization of the receptor-ligand
complex which is directed toward lysosomal degradation or endocytic recycling. Cystic
fibrosis (CF) patients display a robust and uncontrolled inflammatory response to
bacterial infection, suggesting a defect in regulation. This study examined the intracellular
trafficking of TLR4 in CF and non-CF airway epithelial cells following stimulation
with LPS. We employed cells lines [16hBE14o-, CFBE41o- (CF), and CFTR-complemented
CFBE41o-] and confirmed selected experiments in primary nasal epithelial cells from
non-CF controls and CF patients (F508del homozygous). In control cells, TLR4 expression
(surface and cytoplasmic) was reduced after LPS stimulation but remained unchanged
in CF cells and was accompanied by a heightened inflammatory response 24 h after stimulation.
All cells expressed markers of the early (EEA1) and late (Rab7b) endosomes at basal
levels. However, only CF cells displayed persistent expression of Rab7b following
LPS stimulation. Rab7 variants may directly internalize bacteria to the Golgi for
recycling or to the lysosome for degradation. TLR4 colocalized with the lysosomal
marker LAMP1 in 16 hBE14o- cells, suggesting that TLR4 is targeted for lysosomal degradation
in these cells. However, this colocalization was not observed in CFBE41o- cells, where
persistent expression of Rab7 and release of proinflammatory cytokines was detected.
Consistent with the apparent inability of CF cells to target TLR4 toward the lysosome
for degradation, we observed persistent surface and cytoplasmic expression of this
pathogen recognition receptor. This defect may account for the prolonged cycle of
chronic inflammation associated with CF.
Kelly, C., et al. (2013). "Expression of the nuclear factor-kappaB inhibitor A20 is
altered in the cystic fibrosis epithelium." Eur Respir J 41(6): 1315-1323.
A20 is a lipopolysaccharide (LPS)-inducible, cytoplasmic zinc finger protein, which
inhibits Toll-like receptor-activated nuclear factor (NF)-kappaB signalling by deubiquitinating
tumour necrosis factor receptor-associated factor (TRAF)-6. The action of A20 is facilitated
by complex formation with ring finger protein (RNF)-11, Itch and TAX-1 binding protein-1
(TAX1BP1). This study investigated whether the expression of A20 is altered in the
chronically inflamed cystic fibrosis (CF) airway epithelium. Nasal epithelial cells
from CF patients (F508del homozygous), non-CF controls and immortalised epithelial
cells (16HBE14o- and CFBE41o-) were stimulated with LPS. Cytoplasmic expression of
A20 and expression of NF-kappaB subunits were analysed. Formation of the A20 ubiquitin
editing complex was also investigated. In CFBE41o-, peak LPS-induced A20 expression
was delayed compared with 16HBE14o- and fell significantly below basal levels 12-24
h after LPS stimulation. This was confirmed in primary CF airway cells. Additionally,
a significant inverse relationship between A20 and p65 expression was observed. Inhibitor
studies showed that A20 does not undergo proteasomal degradation in CFBE41o-. A20
interacted with TAX1BP1, RNF11 and TRAF6 in 16HBE14o- cells, but these interactions
were not observed in CFBE41o-. The expression of A20 is significantly altered in CF,
and important interactions with complex members and target proteins are lost, which
may contribute to the state of chronic NF-kappaB-driven inflammation.
Kosamo, S., et al. (2020). "Strong toll-like receptor responses in cystic fibrosis
patients are associated with higher lung function." J Cyst Fibros 19(4): 608-613.
BACKGROUND: Cystic fibrosis (CF) airways disease varies widely among patients with
identical cystic fibrosis transmembrane conductance regulator (CFTR) genotypes. Robust
airway inflammation is thought to be deleterious in CF; inter-individual variation
in Toll-like receptor (TLR)-mediated innate immune inflammatory responses (TMIIR)
might account for a portion of the phenotypic variation. We tested if TMIIR in people
with CF are different than those of healthy controls, and whether higher TMIIR in
people with CF are associated with reduced lung function. METHODS: We cultured whole
blood from clinically stable subjects with CF (n = 76) and healthy controls (n = 45)
with TLR agonists, and measured cytokine production and expression of TLR-associated
genes. We tested for differences in TLR-stimulated cytokine levels between subjects
with CF and healthy subjects, and for associations between cytokine and gene expression
levels with baseline lung function (forced expiratory volume in one second percent
predicted (FEV1%)) and decline in FEV1% over time. RESULTS: TMIIR in blood from subjects
with CF were lower than in healthy controls. Expression of TLR regulators SARM1, TOLLIP,
and AKT1 were downregulated in CF. In subjects with CF we found that lower TLR4-agonist-induced
IL-8 was associated with lower FEV1% at enrollment (p<0.001) and with greater five
year FEV1% decline (p<0.001). CONCLUSIONS: TMIIR were lower in people with CF relative
to healthy controls; however, unexpectedly, greater whole blood TMIIR were positively
associated with lung function in people with CF. These findings suggest a complex
interaction between inflammation and disease in people with CF.
Metruccio, M. M., et al. (2016). "Pseudomonas aeruginosa Outer Membrane Vesicles Triggered
by Human Mucosal Fluid and Lysozyme Can Prime Host Tissue Surfaces for Bacterial Adhesion."
Front Microbiol 7: 871.
Pseudomonas aeruginosa is a leading cause of human morbidity and mortality that often
targets epithelial surfaces. Host immunocompromise, or the presence of indwelling
medical devices, including contact lenses, can predispose to infection. While medical
devices are known to accumulate bacterial biofilms, it is not well understood why
resistant epithelial surfaces become susceptible to P. aeruginosa. Many bacteria,
including P. aeruginosa, release outer membrane vesicles (OMVs) in response to stress
that can fuse with host cells to alter their function. Here, we tested the hypothesis
that mucosal fluid can trigger OMV release to compromise an epithelial barrier. This
was tested using tear fluid and corneal epithelial cells in vitro and in vivo. After
1 h both human tear fluid, and the tear component lysozyme, greatly enhanced OMV release
from P. aeruginosa strain PAO1 compared to phosphate buffered saline (PBS) controls
( approximately 100-fold). Transmission electron microscopy (TEM) and SDS-PAGE showed
tear fluid and lysozyme-induced OMVs were similar in size and protein composition,
but differed from biofilm-harvested OMVs, the latter smaller with fewer proteins.
Lysozyme-induced OMVs were cytotoxic to human corneal epithelial cells in vitro and
murine corneal epithelium in vivo. OMV exposure in vivo enhanced Ly6G/C expression
at the corneal surface, suggesting myeloid cell recruitment, and primed the cornea
for bacterial adhesion ( approximately 4-fold, P < 0.01). Sonication disrupted OMVs
retained cytotoxic activity, but did not promote adhesion, suggesting the latter required
OMV-mediated events beyond cell killing. These data suggest that mucosal fluid induced
P. aeruginosa OMVs could contribute to loss of epithelial barrier function during
medical device-related infections.
Muhlebach, M. S., et al. (2018). "Anaerobic bacteria cultured from cystic fibrosis
airways correlate to milder disease: a multisite study." Eur Respir J 52(1).
Anaerobic and aerobic bacteria were quantitated in respiratory samples across three
cystic fibrosis (CF) centres using extended culture methods. Subjects aged 1-69 years
who were clinically stable provided sputum (n=200) or bronchoalveolar lavage (n=55).
18 anaerobic and 39 aerobic genera were cultured from 59% and 95% of samples, respectively;
16 out of 57 genera had a >/=5% prevalence across centres.Analyses of microbial communities
using co-occurrence networks in sputum samples showed groupings of oral, including
anaerobic, bacteria, whereas typical CF pathogens formed distinct entities. Pseudomonas
was associated with worse nutrition and F508del genotype, whereas anaerobe prevalence
was positively associated with pancreatic sufficiency, better nutrition and better
lung function. A higher total anaerobe/total aerobe CFU ratio was associated with
pancreatic sufficiency and better nutrition. Subjects grouped by factor analysis who
had relative dominance of anaerobes over aerobes had milder disease compared with
a Pseudomonas-dominated group with similar proportions of subjects that were homozygous
for F508del.In summary, anaerobic bacteria occurred at an early age. In sputum-producing
subjects anaerobic bacteria were associated with milder disease, suggesting that targeted
eradication of anaerobes may not be warranted in sputum-producing CF subjects.
O'Neill, K., et al. (2015). "Reduced bacterial colony count of anaerobic bacteria
is associated with a worsening in lung clearance index and inflammation in cystic
fibrosis." PLoS One 10(5): e0126980.
Anaerobic bacteria have been identified in abundance in the airways of cystic fibrosis
(CF) subjects. The impact their presence and abundance has on lung function and inflammation
is unclear. The aim of this study was to investigate the relationship between the
colony count of aerobic and anaerobic bacteria, lung clearance index (LCI), spirometry
and C-Reactive Protein (CRP) in patients with CF. Sputum and blood were collected
from CF patients at a single cross-sectional visit when clinically stable. Community
composition and bacterial colony counts were analysed using extended aerobic and anaerobic
culture. Patients completed spirometry and a multiple breath washout (MBW) test to
obtain LCI. An inverse correlation between colony count of aerobic bacteria (n = 41,
r = -0.35; p = 0.02), anaerobic bacteria (n = 41, r = -0.44, p = 0.004) and LCI was
observed. There was an inverse correlation between colony count of anaerobic bacteria
and CRP (n = 25, r = -0.44, p = 0.03) only. The results of this study demonstrate
that a lower colony count of aerobic and anaerobic bacteria correlated with a worse
LCI. A lower colony count of anaerobic bacteria also correlated with higher CRP levels.
These results indicate that lower abundance of aerobic and anaerobic bacteria may
reflect microbiota disruption and disease progression in the CF lung.
Tang, A. C., et al. (2014). "Current concepts: host-pathogen interactions in cystic
fibrosis airways disease." Eur Respir Rev 23(133): 320-332.
Chronic infection and inflammation are defining characteristics of cystic fibrosis
(CF) airway disease. Conditions within the airways of patients living with CF are
conducive to colonisation by a variety of opportunistic bacterial, viral and fungal
pathogens. Improved molecular identification of microorganisms has begun to emphasise
the polymicrobial nature of infections in the CF airway microenvironment. Changes
to CF airway physiology through loss of cystic fibrosis transmembrane conductance
regulator functionality result in a wide range of immune dysfunctions, which permit
pathogen colonisation and persistence. This review will summarise the current understanding
of how CF pathogens infect, interact with and evade the CF host.
Tunney, M. M., et al. (2008). "Detection of anaerobic bacteria in high numbers in
sputum from patients with cystic fibrosis." Am J Respir Crit Care Med 177(9): 995-1001.
RATIONALE: Pulmonary infection in cystic fibrosis (CF) is polymicrobial and it is
possible that anaerobic bacteria, not detected by routine aerobic culture methods,
reside within infected anaerobic airway mucus. OBJECTIVES: To determine whether anaerobic
bacteria are present in the sputum of patients with CF. METHODS: Sputum samples were
collected from clinically stable adults with CF and bronchoalveolar lavage fluid (BALF)
samples from children with CF. Induced sputum samples were collected from healthy
volunteers who did not have CF. All samples were processed using anaerobic bacteriologic
techniques and bacteria within the samples were quantified and identified. MEASUREMENTS
AND MAIN RESULTS: Anaerobic species primarily within the genera Prevotella, Veillonella,
Propionibacterium, and Actinomyces were isolated in high numbers from 42 of 66 (64%)
sputum samples from adult patients with CF. Colonization with Pseudomonas aeruginosa
significantly increased the likelihood that anaerobic bacteria would be present in
the sputum. Similar anaerobic species were identified in BALF from pediatric patients
with CF. Although anaerobes were detected in induced sputum samples from 16 of 20
volunteers, they were present in much lower numbers and were generally different species
compared with those detected in CF sputum. Species-dependent differences in the susceptibility
of the anaerobes to antibiotics with known activity against anaerobes were apparent
with all isolates susceptible to meropenem. CONCLUSIONS: A range of anaerobic species
are present in large numbers in the lungs of patients with CF. If these anaerobic
bacteria are contributing significantly to infection and inflammation in the CF lung,
informed alterations to antibiotic treatment to target anaerobes, in addition to the
primary infecting pathogens, may improve management.
Yang, D., et al. (2019). "Dysregulated Lung Commensal Bacteria Drive Interleukin-17B
Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles." Immunity
50(3): 692-706 e697.
Idiopathic pulmonary fibrosis (IPF) is a severe form of lung fibrosis with a high
mortality rate. However, the etiology of IPF remains unknown. Here, we report that
alterations in lung microbiota critically promote pulmonary fibrosis pathogenesis.
We found that lung microbiota was dysregulated, and the dysregulated microbiota in
turn induced production of interleukin-17B (IL-17B) during bleomycin-induced mouse
lung fibrosis. Either lung-microbiota depletion or IL-17B deficiency ameliorated the
disease progression. IL-17B cooperated with tumor necrosis factor-alpha to induce
expression of neutrophil-recruiting genes and T helper 17 (Th17)-cell-promoting genes.
Three pulmonary commensal microbes, which belong to the genera Bacteroides and Prevotella,
were identified to promote fibrotic pathogenesis through IL-17R signaling. We further
defined that the outer membrane vesicles (OMVs) that were derived from the identified
commensal microbes induced IL-17B production through Toll-like receptor-Myd88 adaptor
signaling. Together our data demonstrate that specific pulmonary symbiotic commensals
can promote lung fibrosis by regulating a profibrotic inflammatory cytokine network.
Zemanick, E. T., et al. (2013). "Inflammation and airway microbiota during cystic
fibrosis pulmonary exacerbations." PLoS One 8(4): e62917.
BACKGROUND: Pulmonary exacerbations (PEx), frequently associated with airway infection
and inflammation, are the leading cause of morbidity in cystic fibrosis (CF). Molecular
microbiologic approaches detect complex microbiota from CF airway samples taken during
PEx. The relationship between airway microbiota, inflammation, and lung function during
CF PEx is not well understood. OBJECTIVE: To determine the relationships between airway
microbiota, inflammation, and lung function in CF subjects treated for PEx. METHODS:
Expectorated sputum and blood were collected and lung function testing performed in
CF subjects during early (0-3d.) and late treatment (>7d.) for PEx. Sputum was analyzed
by culture, pyrosequencing of 16S rRNA amplicons, and quantitative PCR for total and
specific bacteria. Sputum IL-8 and neutrophil elastase (NE); and circulating C-reactive
protein (CRP) were measured. RESULTS: Thirty-seven sputum samples were collected from
21 CF subjects. At early treatment, lower diversity was associated with high relative
abundance (RA) of Pseudomonas (r = -0.67, p<0.001), decreased FEV(1%) predicted (r
= 0.49, p = 0.03) and increased CRP (r = -0.58, p = 0.01). In contrast to Pseudomonas,
obligate and facultative anaerobic genera were associated with less inflammation and
higher FEV(1). With treatment, Pseudomonas RA and P. aeruginosa by qPCR decreased
while anaerobic genera showed marked variability in response. Change in RA of Prevotella
was associated with more variability in FEV(1) response to treatment than Pseudomonas
or Staphylococcus. CONCLUSIONS: Anaerobes identified from sputum by sequencing are
associated with less inflammation and higher lung function compared to Pseudomonas
at early exacerbation. CF PEx treatment results in variable changes of anaerobic genera
suggesting the need for larger studies particularly of patients without traditional
CF pathogens.
Zemanick, E. T. and L. R. Hoffman (2016). "Cystic Fibrosis: Microbiology and Host
Response." Pediatr Clin North Am 63(4): 617-636.
The earliest descriptions of lung disease in people with cystic fibrosis (CF) showed
the involvement of 3 interacting pathophysiologic elements in CF airways: mucus obstruction,
inflammation, and infection. Over the past 7 decades, our understanding of CF respiratory
microbiology and inflammation has evolved with the introduction of new treatments,
increased longevity, and increasingly sophisticated laboratory techniques. This article
reviews the current understanding of infection and inflammation and their roles in
CF lung disease. It also discusses how this constantly evolving information is used
to inform current therapeutic strategies, measures and predictors of disease severity,
and research priorities.
- Attachments
- Attachment
Submitted filename: Response to Reviewers - Bertelsen - 16Sept 2020.docx